Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835]

doi:10.1186/bcr1505

Research article

Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835]

Vasso Apostolopoulos^*, Geoffrey A Pietersz, Anastasios Tsibanis, Annivas Tsikkinis, Heleni Drakaki, Bruce E Loveland, Sara J Piddlesden, Magdalena Plebanski, Dodie S Pouniotis, Michael N Alexis, Ian F McKenzie and Stamatis Vassilaros

* Corresponding author: Vasso Apostolopoulos vasso@burnet.edu.au

Breast Cancer Research 2006, 8:R27 doi:10.1186/bcr1505

No comments have yet been made on this article.

Breast Cancer Research

Viewing options

Associated material

Tools

Share this article

Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835]

Breast Cancer Research

Viewing options

Associated material

Related literature

Cited by

Other articles by authors

Related articles/pages

Tools

Share this article

Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835]